Polio Eradication and Surveillance. December

Similar documents
Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

宮村参考人提出資料 資料 2-2

Global Measles and Rubella Update November 2018

Global Measles and Rubella Update. April 2018

Global Measles and Rubella Update October 2018

VPD in Mediterranean Basin and Black Sea: the Polio case

Getting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Wild Poliovirus Weekly Update

Update on Progress and Challenges in Achieving Measles and Rubella Targets

Status of Outbreak Vulnerable Countries

Poliomyelitis: successful and critical issues in the eradication process

Global Polio Eradication & Endgame Strategy. December 2015

Poliovirus : éradication pour les prochaines JNI?

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

Summary of findings, decisions and recommendations

Global ProhrammeUpdate?

Programme Update. Transition Independent Monitoring Board London, 2 November Geneva, 23 October 2017

Wild poliovirus type 1 and Circulating vaccine-derived poliovirus cases

Immunization and Vaccine Development (IVD) SEARO

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO

Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO

#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR)

Development of the Polio Eradication and Endgame Strategic plan

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges

Expanded Programme on Immunization (EPI)

Selected vaccine introduction status into routine immunization

Immunization and Vaccine Development (IVD) SEARO

Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions

Summary of findings, decisions and recommendations

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

Polio Eradication: Beginning of the End, or End of the Beginning?

Report of the 23rd Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

Current Situation on Avian Influenza and the pandemic threat

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Expanded Programme on Immunization (EPI)

Draft Programme (05 May 2016)

Regional Overview of the implementation of National Control Strategies for Avian Influenza. Summary review of questionnaire OIE RRAP

Progress report on eradication of poliomyelitis: regional implications of the endgame strategy

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Guidance for Travelers on Temporary Work Assignment Abroad

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO

Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus

Expanded Programme on Immunization (EPI)

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

31 May to 2 June 2016 // Copenhagen, Denmark. 30th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

Vaccination Recommendations for Travellers from Polio-infected Countries: Report of the SAGE Polio Working Group

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

Report of the 27th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

USAID Progress: The U.S. National Vaccine Plan of 1994

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Maintaining Polio-Free Certification in the World Health Organization Western Pacific Region for Over a Decade

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Welcome to the new EURO Immunization Monitor

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting

Report of the Polio WG Meeting February Dr. Peter Figueroa Co-Chair, SAGE Polio Working Group 17 April, 2018

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Experiences on Workforce Development in Other Regions

Global eradication of poliomyelitis

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014

TECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING. Gavi Board pre-meeting December 9, 2014, Geneva.

Why still Polio Donato Greco ECDC polio consultant 14 April 2016

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Report of the 26th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

Table 1: Basic information 2017

The Polio Endgame

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO

The Global Commission for the Certification of Polio Eradication (GCCPE)

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

Humanitarian Initiative to Prepare for a Pandemic Influenza Emergency (HIPPIE) Ron Waldman, MD Avian and Pandemic Influenza Unit USAID/Washington

The State of Measles and Rubella in the WHO European Region

Expanded Programme on Immunization (EPI)

FAOAIDEnews Animal Influenza Disease Emergency

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

THE CARE WE PROMISE FACTS AND FIGURES 2017

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts

CEO Board report Seth Berkley MD CEO

Immunization Update & focus on meningococcal vaccine PART 1

Environmental Surveillance for Polioviruses in the Global Polio Eradication Initiative

REPORT OF THE 31ST MEETING OF THE EUROPEAN REGIONAL CERTIFICATION COMMISSION FOR POLIOMYELITIS ERADICATION (RCC)

OFFLU AVIAN INFLUENZA REPORT

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC

MARKET NEWS for pig meat

Transcription:

Polio Eradication and Surveillance December 2017 1

Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2

Global Laboratory Network for Polio Eradication N = 146 laboratories Specialised Reference Laboratory (6) Regional Reference Laboratory (17) National/ Sub-national Laboratory (123) December 2017 3

Virus linked to common ancestor, West and Central Africa, 2004 7 August14 December 2017 4

WPV1 by genetic cluster and quarter, Pakistan 2009 and 2010 2009 1 st Quarter 2 st Quarter 3 rd Quarter 4 th Quarter 2010 Case A3- A3- A1A A1A A3-A2 A3-D2 B4- Pending A3-A2 A3-D2 A1 Pending The August 18 Ghotki case is most closely related to the Jan 2010 Karachi Gadap env. virus (99.3%) and to a Sept 2009 Muzaffarghar case (99.2%) December 2017 5

Progress in polio eradication, West Africa, 2008-2010 2008 Genetic Clusters of Poliovirus 1 2008 2009 2010 2009 2010 December 2017 6

Acute flaccid paralysis (AFP) surveillance system: targets AFP reporting (AFP reporting rate) > 1 report < 15 years of age per 100 000 Specimen collection (stool collection rate) > 80% samples collected within 14 days of onset December 2017 7

AFP reporting rate world-wide, 2015 and 2016 February 2015 January 2016 February 2016 January 2017 < 0.5 0.5-0.99 >1 No AFP Surveillance/data Data in WHO HQ as of 14 March 2017 December 2017 8

Stool collection rate world-wide, 2015 and 2016 February 2015 January 2016 February 2016 January 2017 < 60% 60% -79.99% >80% No AFP Surveillance/data Data in WHO HQ as of 14 March 2017 December 2017 9

Afghanistan Quality key AFP surveillance indicators (by province) December 2017 10

Polio AFP surveillance officers and staff Surveillance focal points in central government and provinces/states/districts Each has polio-funded driver with vehicle Per diem for surveillance staff and driver for 10 field days per month Fuel, local maintenance of vehicle Specimen collection Real-time communication (cell or satellite phone, laptop) December 2017 11

Polio AFP surveillance network: an active surveillance and response system Accurately identifies children with acute flaccid paralysis Investigates each child, collects and transports specimens to laboratory Analyzes specimen results, determines where polio is, and where polio is not Ensures supervised vaccination response, "pulling" vaccines from manufacturers to national stores and children providing over 90% access Maintains vehicles, cell and satellite phones, computers, offices and office equipment/supplies, laboratory equipment and supplies December 2017 12

Micro-planning and mapping for Immunization campaigns in rural Pakistan December 2017 13

Other activities of polio-funded AFP surveillance staff since 2002 Case reporting/investigation: Cholera, meningitis sub-saharan Africa, periodic since 2002 Haemorrhagic fever Afghanistan/Pakistan border, 2002 SARS, 2003 First response epidemiological assessment Tsunami South Asia, 2004 Pakistan earthquake, 2005 December 2017 14

Marburg Viral Haemorrhagic Fever Angola, 2005 50 45 Adult Child 40 35 30 25 20 3 15 10 5 0 December 2017 15

Ebola outbreak, Nigeria, 2014 December 2017 16

Expansion of the polio-funded AFP surveillance network: measles, rubella, yellow fever December 2017 17

Potential for further expansion, polio-funded AFP surveillance network Influenza 66/112 current influenza labs are located in the same institute as polio laboratories Lab assessments combined with polio and/or measles accreditation reviews Links with Polio and Measles for virus culture and molecular techniques Other viral diseases Japanese Encephalitis Dengue Rotavirus HPV Bacterial diseases Hib Pneumococcus Meningococcus December 2017 18

Polio-funded staff by region, 2005 Region International Staff National Staff FT ST* FT ST* SSA NPO APW Total AFRO 31 120 5 572 355 14 0 1097 AMRO 1 0 0 3 0 2 0 6 EMRO 13 83** 7 19 439 0 457 935 EURO 2 1.5 2 2 0 2 0 9.5 SEARO 13 12 5 11 1151 0 0 1192 WPRO 2 0 0 0 1 0 0 3 HQ 23 12 11.5 4.5 0 0 0 51 TOTAL 85 145.5 30.5 611.5 1946 18 457 3293.5 December 2017 19

Polio environmental surveillance (ES) December 2017 Global Polio Laboratory Network 20

Environmental polio surveillance, Locations sampled in Mumbai, India open sewage, Mumbai, India 1 2 F ward G M 1 6 G ward F Photos courtesy Jagadish Deshpande, Entero Virus Research Centre, Mumbai 1 4 M ward December 2017 21

Polio virus Detected In Sewage in Mumbai, India 2005-2009 WPV introductions from UP and Bihar with limited circulation in Mumbai VDPVs detected for the first time in 2009 December 2017 22 Data as of 07 Dec 2009

Environmental polio surveillance, sewage network, Cairo, Egypt Sewage Plant BLIND MONITORING Risk AREA December 2017 23

Poliovirus isolated from sewage by week, Egypt, August 2004 August 2005 12 10 8 6 4 Wild poliovirus type 1 Sabin poliovirus type 1 2 0 32 34 36 38 40 42 44 46 48 50 52 2 4 6 8 10 12 14 16 18 20 22 24 26 2004 2005 year December 2017 24

Pakistan: Environmental Surveillance, Quetta and Peshawar, 2017 Lahore Multan Rawalpindi Karachi Peshawar Quetta Block 25 December 2017 25

Environmental Surveillance, Africa, 2017 December 2017 26

Environmental Surveillance in other polio non-endemic countries Countries with established ES Surveillance and reporting to WHO No Planned AMR Mexico, Haiti 2 Guatemala EUR Azerbadjian, Belarus, Georgia, Kyrgystan, Kazakhstan, Latvia, Lithuania, Moldova, Russian Federation, Turkey, Ukraine, Italy, Estonia, Finland, Croatia, Netherlands, UK, Czech, Slovakia, Greece, Israel, Italy, Spain, Uzbekistan, Romania 25 - SEAR India, Indonesia, Thailand, Bangladesh, Myanmar 5 Nepal, Timor-Leste WPR China, Philippines, Australia, 3 PNG, Vietnam, Cambodia, Laos December 2017 27

Containment after certification of poliovirus after eradication Polio virus in laboratories throughout the world: Known wild poliovirus Known Sabin poliovirus Potential infectious materials (wild and Sabin poliovirus) Wild and Sabin poliovirus used in production of inactivated polio vaccine (IPV) December 2017 28

Possible role of environmental surveillance in the future: antimicrobial resistance Shared microbes at the animal/human interface Plants Source: DARC/ARHAI joint report, UKI December 2017 29

View from outside Eradication of wild poliovirus Type 2 has been certified before containment has been completed December 2017 30

View from outside Eradication of wild poliovirus Type 2 has been certified before containment has been completed GCC will likely follow precedent eradication certified with interruption of transmission of wild poliovirus Types 1 and 3 December 2017 31

View from outside Eradication of wild poliovirus Type 2 has been certified before containment has been completed GCC will likely follow precedent eradication certified with interruption of transmission of wild poliovirus Types 1 and 3 Is it time for WHO to integrate surveillance and containment with other activities in surveillance (IHR) and biosecurity of WHO while there are still resources available, and in view of the need for long term sustainability? December 2017 32